$1.07 Billion is the total value of Vivo Capital, LLC's 46 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals Inc | $84,379,000 | +9.8% | 3,375,169 | 0.0% | 7.91% | +3.2% | |
| IOVA | Iovance Biotherapeutics, Inc. | $39,232,000 | +157.8% | 1,600,000 | 0.0% | 3.68% | +142.3% | |
| SVA | Sinovac Biotech Ltd. | $38,173,000 | 0.0% | 5,900,000 | 0.0% | 3.58% | -6.0% | |
| KALV | KalVista Pharmaceuticals Inc. | $30,105,000 | -22.6% | 1,359,149 | 0.0% | 2.82% | -27.3% | |
| KDMN | Kadmon Holdings Inc | $25,970,000 | -22.0% | 12,606,605 | 0.0% | 2.43% | -26.7% | |
| MNLO | Menlo Therapeutics Inc. | $24,027,000 | -23.7% | 4,011,236 | 0.0% | 2.25% | -28.3% | |
| FIXX | Homology Medicines, Inc. | $22,696,000 | -29.4% | 1,159,742 | 0.0% | 2.13% | -33.7% | |
| EIGR | Eiger BioPharmaceuticals Inc | $18,987,000 | -24.2% | 1,791,257 | 0.0% | 1.78% | -28.8% | |
| XENE | Xenon Pharmaceuticals Inc | $13,858,000 | -3.0% | 1,405,476 | 0.0% | 1.30% | -8.8% | |
| KNSA | Kiniksa Pharmaceuticals | $11,421,000 | -25.0% | 843,478 | 0.0% | 1.07% | -29.6% | |
| OBSV | Obseva SA | $10,599,000 | -11.6% | 937,147 | 0.0% | 0.99% | -16.9% | |
| APLS | Apellis Pharmaceuticals, Inc. | $9,719,000 | +30.0% | 383,538 | 0.0% | 0.91% | +22.1% | |
| VRNA | Verona Pharma PLCads | $7,614,000 | -21.5% | 1,492,951 | 0.0% | 0.71% | -26.2% | |
| GLMD | Galmed Pharmaceuticals Ltd | $7,139,000 | -10.0% | 971,337 | 0.0% | 0.67% | -15.4% | |
| DERM | Dermira Inc | $6,692,000 | -29.4% | 700,000 | 0.0% | 0.63% | -33.7% | |
| KALA | Kala Pharmaceuticals, Inc. | $6,654,000 | -22.9% | 1,043,020 | 0.0% | 0.62% | -27.4% | |
| MTNB | Matinas Biopharma Hldgs Inc | $5,840,000 | -21.4% | 6,818,181 | 0.0% | 0.55% | -26.2% | |
| ZGNX | Zogenix Inc | $5,017,000 | -13.1% | 105,000 | 0.0% | 0.47% | -18.4% | |
| DTIL | Precision Biosciences Inc | $3,717,000 | -26.2% | 280,511 | 0.0% | 0.35% | -30.7% | |
| ACRS | Aclaris Therapeutics, Inc. | $3,607,000 | -63.4% | 1,647,214 | 0.0% | 0.34% | -65.7% | |
| DBVT | DBV Technologies S.A.adr | $2,219,000 | +6.6% | 269,995 | 0.0% | 0.21% | 0.0% | |
| AGRX | Agile Therapeutics, Inc. | $2,210,000 | -3.3% | 1,513,975 | 0.0% | 0.21% | -9.2% | |
| SRRA | Sierra Oncology, Inc | $1,365,000 | -67.3% | 2,438,270 | 0.0% | 0.13% | -69.2% | |
| SELB | Selecta Biosciences Inc | $977,000 | -24.2% | 546,054 | 0.0% | 0.09% | -28.7% | |
| AKTX | Akari Therapeutics Plcadr | $699,000 | -43.5% | 345,850 | 0.0% | 0.07% | -46.3% | |
| SLNOW | Soleno Therapeutics, Inc. - Warrantwarrant | $19,000 | -32.1% | 188,772 | 0.0% | 0.00% | -33.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.